![[D-p-Cl-Phe6,Leu17]-VIP TFA](https://file.medchemexpress.com/product_pic/hy-p1159a.gif "Click to View [D-p-Cl-Phe6,Leu17]-VIP TFA Product Detail")
![[K15,R16,L27]VIP(1-7)/GRF(8-27) acetate](https://file.medchemexpress.com/product_pic/hy-p4195a.gif "Click to View [K15,R16,L27]VIP(1-7)/GRF(8-27) acetate Product Detail")
![[D-p-Cl-Phe6,Leu17]-VIP](https://file.medchemexpress.com/product_pic/hy-p1159.gif "Click to View [D-p-Cl-Phe6,Leu17]-VIP Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
67 Results for "
VIP
" in MedChemExpress (MCE) Product Catalog:
Products (67)
67 Results for "VIP" in MCE Product Catalog:
5
5 Cited Publications
Cat. No.: HY-P0221
CAS No.: 137061-48-4
Synonyms: Pituitary Adenylate Cyclase Activating Polypeptide 38
Research Areas:
2
2 Cited Publications
Cat. No.: HY-P0012
CAS No.: 40077-57-4
Synonyms: Vasoactive Intestinal Peptide (human, rat, mouse, rabbit, canine, porcine)
Target:
Research Areas:
2
2 Cited Publications
Synonyms: (+)-BAY-1251152; (+)-VIP152; (S)-Enitociclib
Target:
Research Areas:
Enitociclib ((+)-BAY-1251152; (+)-VIP152) is a selective CDK9 inhibitor (IC50=3 nM) that inhibits transcriptional elongation by blocking Ser2/Ser5 phosphorylation of RNA polymerase II. Enitociclib specifically depletes key short-lived proteins such as c-MYC, MCL-1 and induces tumor cell apoptosis. Enitociclib also interferes with the production of enhancer RNAs (eRNA) and enhancer-promoter interactions, and downregulates oncogene expression at the epigenetic level. Enitociclib exerts synergistic effects with agents including Bortezomib (HY-10227), Lenalidomide (HY-A0003), Pomalidomide (HY-10984), Venetoclax (HY-15531) and Paclitaxel (HY-B0015), and even reverses paclitaxel resistance. Enitociclib serves as a vital research tool for various malignancies such as double-hit diffuse large B-cell lymphoma, multiple myeloma and pancreatic ductal adenocarcinoma .
2
2 Cited Publications
Cat. No.: HY-P0220A
Target:
Research Areas:
2
2 Cited Publications
Cat. No.: HY-P0220
CAS No.: 143748-18-9
Target:
Research Areas:
2
2 Cited Publications
Synonyms: (R)-Enitociclib; (-)-BAY-1251152; (-)-VIP152
Target:
Research Areas:
(-)-Enitociclib ((R)-Enitociclib) is an enantiomer of Enitociclib (HY-103019E) with an optical rotation of (-). Enitociclib is a selective CDK9 inhibitor and apoptosis inducer. Enitociclib inhibits CDK9 activity and reduces the phosphorylation of Ser2 in the carboxyl-terminal domain (CTD) of RNA polymerase Pol II, thereby downregulating the transcription of key oncogenes such as MYC and MCL1. Enitociclib has anti-proliferative activity targeting MYC + lymphoma and multiple myeloma (MM) cells, and has synergistic effects with Bortezomib (HY-10227) and Lenalidomide (HY-A0003), and can be used in the research of hematological malignancies .
2
2 Cited Publications
Cat. No.: HY-P0012A
CAS No.: 1444827-29-5
Synonyms: Vasoactive Intestinal Peptide acetate salt (human, rat, mouse, rabbit, canine, porcine)
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P1023
CAS No.: 69698-54-0
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P1159A
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P71061
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VIP; VIP peptides; Intestinal peptide PHV-42; Peptide histidine valine 42; PHV-42; Intestinal peptide PHM-27; Peptide histidine methioninamide 27; PHM-27; Vasoactive intestinal peptide; Vasoactive intestinal polypeptide; Vasoactive Intestinal Peptide; Pre
Species:
Human
Source:
HEK293
Synonyms: (±)-BAY-1251152; (±)-VIP152
Target:
Research Areas:
(±)-Enitociclib ((±)-BAY-1251152) is the racemic mixture of Enitociclib (HY-103019E). Enitociclib is a selective CDK9 inhibitor and apoptosis inducer. Enitociclib inhibits CDK9 activity and reduces the phosphorylation of Ser2 in the carboxyl-terminal domain (CTD) of RNA polymerase Pol II, thereby downregulating the transcription of key oncogenes such as MYC and MCL1. Enitociclib has anti-proliferative activity targeting MYC + lymphoma and multiple myeloma (MM) cells, and has synergistic effects with Bortezomib (HY-10227) and Lenalidomide (HY-A0003), and can be used in the research of hematological malignancies .
Cat. No.: HY-P5005
CAS No.: 125093-93-8
Target:
Research Areas:
Cat. No.: HY-P11288
CAS No.: 2871680-36-1
Target:
Research Areas:
Cat. No.: HY-P11288A
Target:
Research Areas:
Cat. No.: HY-P10948A
Target:
Research Areas:
Cat. No.: HY-P4195A
Target:
Research Areas:
Cat. No.: HY-P4776
CAS No.: 202463-00-1
Target:
Research Areas:
Cat. No.: HY-P1159
CAS No.: 102805-45-8
Target:
Research Areas:
Cat. No.: HY-164429
CAS No.: 2418533-90-9
VIP236 is a small-molecule drug conjugate targeting αvβ3 integrin. VIP236 achieves tumor homing via specific binding to αvβ3 integrin and delivers its payload to the tumor microenvironment. The linker of VIP236 is cleavable by neutrophil elastase, which is highly expressed in the tumor microenvironment, to release the payload 7-ethylcamptothecin. This payload induces DNA damage by inhibiting topoisomerase 1, thereby exerting anti-tumor effects. VIP236 exhibits excellent plasma stability and tumor targeting property, with a tumor/plasma payload ratio 10-fold higher than that of the single administration. It effectively induces tumor regression, reduces metastasis formation, and shows good tolerance in mouse models. VIP236 has been used in studies related to non-small cell lung cancer, clear cell renal cell carcinoma, colon cancer, triple-negative breast cancer, small cell lung cancer, and metastatic solid tumors .
Cat. No.: HY-P1015
CAS No.: 96886-24-7
Synonyms: Vasoactive Intestinal Peptide, guinea pig
Target:
Research Areas:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
